AARTI DRUGS LTD.
BSE: 524348
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 631.68+19.5% | 528.80-8.7% | 578.95+11.1% | 520.96-16.4% | 622.96+21.1% | 514.54-5.3% | 543.09 |
| Other Income | 0.83-32.0% | 1.22+713.3% | 0.15-60.5% | 0.38-77.8% | 1.71-85.0% | 11.37+2892.1% | 0.38 |
| Total Income | 632.51+19.3% | 530.02-8.5% | 579.10+11.1% | 521.34-16.5% | 624.67+18.8% | 525.91-3.2% | 543.47 |
| EXPENSES | |||||||
| Expenditure | 573.95+12.9% | 508.31-2.9% | 523.32+9.9% | 476.09-14.1% | 554.00+16.9% | 473.88-5.7% | 502.58 |
| Tax | 13.60+212.1% | -12.13-186.6% | 14.00+513.0% | -3.39-136.9% | 9.19-31.9% | 13.50+28.6% | 10.50 |
| PROFIT | |||||||
| PBT | 58.56+169.7% | 21.71-61.1% | 55.78+23.3% | 45.25-36.0% | 70.67+35.8% | 52.03+27.2% | 40.89 |
| Net Profit | 44.96+32.9% | 33.84-19.0% | 41.78-14.1% | 48.64-20.9% | 61.48+59.6% | 38.53+26.8% | 30.39 |
| KEY METRICS | |||||||
| OPM % | 12.55%+4.55pp | 8.00%-4.99pp | 12.99%+0.71pp | 12.28%-1.95pp | 14.23%+10.14pp | 4.09%+0.13pp | 3.96% |
| NPM % | 7.11%+0.73pp | 6.38%-0.83pp | 7.21%-2.12pp | 9.33%-0.51pp | 9.84%+2.51pp | 7.33%+1.74pp | 5.59% |
| EPS | 4.93+32.9% | 3.71-19.0% | 4.58-14.1% | 5.33-20.9% | 6.74+59.7% | 4.22+26.7% | 3.33 |
Corporate Events
Board MeetingAARTIDRUGS
20263Feb
Board Meeting
Consider and approve Audited Financial Results (Standalone a…
BSE Filing ↗ Board MeetingAARTIDRUGS
202518Jul
Board Meeting
Consider and approve Audited financial results
BSE Filing ↗ Board MeetingAARTIDRUGS
202424Oct
Board Meeting
Audited financial results, Consider, Approve, Take on record
BSE Filing ↗ Board MeetingAARTIDRUGS
20243May
Board Meeting
consider and approve Audited Financial Results
BSE Filing ↗ Board MeetingAARTIDRUGS
202424Jan
Board Meeting
Consider and approve Quarterly Audited Financial results for…
BSE Filing ↗ Board MeetingAARTIDRUGS
202319Oct
Board Meeting
Consider and approve Audited Financial Results for the quart…
BSE Filing ↗